These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2298466)

  • 41. Acute interaction of vasopressin and neurogenic mechanisms in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H37-43. PubMed ID: 7058911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic kinin receptor blockade induces hypertension in deoxycorticosterone-treated rats.
    Madeddu P; Anania V; Parpaglia PP; Demontis MP; Varoni MV; Fattaccio MC; Glorioso N
    Br J Pharmacol; 1993 Mar; 108(3):651-7. PubMed ID: 8385532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differing hemodynamic responses to atrial natriuretic factor in two models of hypertension.
    Volpe M; Sosa RE; Müller FB; Camargo MJ; Glorioso N; Laragh JH; Maack T; Atlas SA
    Am J Physiol; 1986 May; 250(5 Pt 2):H871-8. PubMed ID: 2939731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of chloride in the sympathetic nervous system in DOCA-salt hypertension.
    Motoyama T; Sano H; Miki T; Suzuki H; Kawaguchi K; Furuta Y; Fukuzaki H
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):287-90. PubMed ID: 3390322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of high calcium intake on intracellular free [Ca2+] and Na(+)-H+ exchange in DOC-NaCl-hypertensive rats.
    Wuorela H
    Pharmacol Toxicol; 1992 Nov; 71(5):376-82. PubMed ID: 1448451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 19-nor-deoxycorticosterone excretion in rats bred for susceptibility and resistance to the hypertensive effects of salt.
    Dale SL; Holbrook MM; Melby JC
    Endocrinology; 1985 Dec; 117(6):2424-7. PubMed ID: 4065039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC).
    Aguas AP; Nickerson PA
    Am J Pathol; 1983 Jan; 110(1):48-54. PubMed ID: 6849371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular changes associated with deoxycorticosterone-NaCl-induced hypertension.
    Lee RM; Richardson M; McKenzie R
    Blood Vessels; 1989; 26(3):137-56. PubMed ID: 2790213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics of hormonal and neurogenic mechanisms of deoxycorticosterone-induced hypertension.
    Ueno Y; Mohara O; Brosnihan KB; Ferrario CM
    Hypertension; 1988 Feb; 11(2 Pt 2):I172-7. PubMed ID: 3346052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of potassium loading and sodium depletion on DOC induced hypertension in sheep.
    Mills EH; Coghlan JP; Denton DA; Spence CD; Whitworth JA; Scoggins BA
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):521-6. PubMed ID: 6475458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Similar blood pressure but different outcome in rats with DOC and post-DOC hypertension.
    Reid R; Lindop G; Brown W; Lever AF; Lucie N; Webb D
    J Hypertens; 1983 Oct; 1(3):303-10. PubMed ID: 6681045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aqueduct block markedly reduces mortality and hypertension in post-deoxycorticosterone acetate Dahl salt-resistant rats.
    Lee JY; Tobian L
    Hypertension; 1991 Jun; 17(6 Pt 2):1197-203. PubMed ID: 2045165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    J Hypertens; 1988 May; 6(5):381-7. PubMed ID: 3385203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exaggerated natriuresis in the conscious spontaneously hypertensive rat.
    Willis LR; McCallum PW; Higgins JT
    J Lab Clin Med; 1976 Feb; 87(2):265-72. PubMed ID: 1245791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The area postrema in deoxycorticosterone-salt hypertension in rats.
    Fink GD; Pawloski CM; Blair ML; Mangiapane ML
    Hypertension; 1987 Jun; 9(6 Pt 2):III206-9. PubMed ID: 2885274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension.
    Hatzinikolaou P; Gavras H; Brunner HR; Gavras I
    Am J Physiol; 1981 Jun; 240(6):H827-31. PubMed ID: 7246746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.